These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2005-002369-35 Reduction of pain under pressure of an experimentally induced hematoma in healthy volunteers by two Bromelain preparations (Bromelain-POS(R) and Traumanase(R) forte). 2006-07-13 due-trials
Reported results 2005-005654-53 "Explorative triple-arm dosis-finding study for examination about the effectivity and tolerance of Bromelain by acute sinusitis" 2007-09-04 due-trials
Completed, but no date, and reported results 2006-001783-23 A randomized, double-masked, placebo-controlled two cross-over study comparing the effects of moxaverine and placebo on ocular blood flow bad-data
Reported results 2007-005607-18 An open study comparing the effects of moxaverine on ocular blood flow in patients with age- related macular degeneration, primary open angle glaucoma and healthy control subjects 2007-03-11 due-trials
Reported results 2009-015804-24 Perioperative Ödemtherapie mit Bromelain nach Weisheitszahnosteotomien – Überprüfung der Wirksamkeit in Abhängigkeit von unterschiedlichen Dosierungen (Dosisfindungsstudie) 2014-08-01 due-trials
Reported results 2009-017789-22 A randomized, placebo-controlled study investigating the effects of moxaverine on ocular blood flow after oral administration in healthy subjects 2011-03-29 due-trials
Reported results 2013-003896-37 Efficacy and tolerability of Bromelain tablets hysan® in patients with chronic rhinosinusitis. A prospective, double-blind, randomized, placebo-controlled multi-centre trial. A proof of concept study.... 2015-01-08 due-trials
Completed, report not yet due Terminated 2020-005523-37 A prospective controlled proof-of-concept trial to demonstrate anti-viral effects of oral bromelaine in COVID-19 positive patients Eine prospektive kontrollierte Proof-of-Concept-Studie zum Nachwei... 2022-02-14 not-yet-due
Reported results 2020-005544-34 Double-blind placebo-controlled proof-of-concept trial to demonstrate the anti-viral efficacy of different doses of azelastine in COVID-19 positive patients. Doppelblinde, Placebo-kontrollierte Pro... 2021-06-30 due-trials